The upgrade in the price target from $5 to $8 by a reputable analyst firm like HC Wainwright & Co. is a strong positive signal for Nuvation Bio. It suggests increased confidence in the company's future performance and potential for growth, which is likely to positively influence investor sentiment and potentially lead to a short-term increase in the stock price.